Summary
October 2007, Vol. 16, No. 10, Pages 1725-1734 , DOI 10.1517/13543784.16.10.1725

14th Annual Meeting of the Psychoneuroimmunology Research Society
28 – 29 May 2007, Bordeaux, France

Martin Braddock
Discovery Bioscience, AstraZeneca R & D Charnwood, Bakewell Road, Loughborough, LE11 5RH, Leicestershire, England, UK +44(0) 150 964 4000; +44(0) 150 964 5574;



The Association for Neurophyschopharmacology hosted a satellite meeting as part of the 14th Annual Meeting of the Psychoneuroimmunology Research Society. The meeting was entitled ‘Cytokines and Depression III: Identification and Treatment of Symptoms Associated with Inflammation in Diseases with Inflammation in Medically Ill Patients’ and was held in Bordeaux, France on 28 – 29 May, 2007. The meeting comprised 40 participants from many leading laboratories and hospitals from around the world looking to understand some of the clinical issues associated with depression and behavioural changes, with the aims of exploring better ways of clinical monitoring and marshalling drug discovery efforts from bespoke and alternate indications in providing new therapeutic approaches.

Full Text | PDF (137 KB) | PDF Plus (294 KB)
 

Prev. Article | Next Article
View/Print PDF (137 KB)
View PDF Plus (294 KB)
Add to favourite
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Author:
Martin Braddock
Keywords:
clinical depression
co-morbidites
cytokines
sickness behaviour